Tag: Lecanemab
Biogen idec: English marketing application for lecanemab
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Biogen: English marketing application for lecanemab
(CercleFinance.com) – Eisai Co and Biogen Inc. announced yesterday that Eisai has submitted a marketing authorization (MA) application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for lecanemab.…
Biogen is hoping for a fresh start with lecanemab
The US company Biogen is under pressure after the debacle at the launch of its first Alzheimer’s drug. Thanks to a promising second product, he has the chance for a…
Lecanemab: Biogen launches new Alzheimer’s drug
According to the company, the antibody lecanemab slows down mental decay in Alzheimer’s patients. That sounds hopeful. The only question is: hopeful for the patients or the manufacturers? The world…